New injection tested against established drug in early safety trial
NCT ID NCT07366632
Summary
This early-stage study aims to understand the safety and how long a new injection called BL0175 stays in the blood of healthy postmenopausal women. Researchers will compare it to an existing drug called fulvestrant. The trial will enroll 27 participants who will receive one dose of either injection to monitor for side effects and measure blood levels.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for POSTMENOPAUSAL WOMEN are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.